Ligand validation:3V1H

INS: 1,2,3,4,5,6-HEXAHYDROXY-CYCLOHEXANE

INS is a Ligand Of Interest in 3V1H designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3V1H_INS_A_401	42%	33%	0.188	0.907	0.91	1.72	-	7	1	0	100%	1
4I9T_INS_A_502	85%	41%	0.11	0.974	0.58	1.67	-	5	0	0	100%	1
4RV3_INS_A_402	69%	11%	0.095	0.907	1.41	2.7	1	9	2	0	100%	1
3V16_INS_A_401	44%	38%	0.181	0.907	1.05	1.37	-	2	0	0	100%	1
4S3G_INS_A_401	29%	27%	0.135	0.793	0.88	2.05	-	6	1	0	100%	1
4F2B_INS_A_401	20%	76%	0.219	0.82	0.55	0.4	-	-	1	0	100%	1
4RU1_INS_B_401	100%	42%	0.024	0.993	0.83	1.41	-	2	0	0	100%	1
4YO7_INS_A_405	100%	54%	0.041	0.984	0.92	0.86	1	-	0	0	100%	1
5FYR_INS_B_301	93%	14%	0.069	0.963	1.37	2.5	1	8	0	0	100%	1
5YSQ_INS_A_301	86%	54%	0.079	0.948	0.84	0.92	-	1	0	0	100%	1
4WRE_INS_A_403	75%	40%	0.099	0.931	1.44	0.91	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.